UnitedHealth Group Names Two New Directors
07 August 2017 - 8:50PM
Business Wire
- Dr. Valerie Montgomery Rice,
President and Dean of the Morehouse School of Medicine
- Sir Andrew Witty, former CEO and
Director of GlaxoSmithKline; Chancellor of the University of
Nottingham
The board of directors of UnitedHealth Group (NYSE: UNH)
announced Valerie Montgomery Rice, M.D., and Sir Andrew Witty have
joined the board.
Richard Burke, chairman of the board of directors of
UnitedHealth Group, said, “Valerie Montgomery Rice and Andrew Witty
both have broad firsthand experience in health systems and research
and the application of modern health care data and analytics. Each
is a leading thinker on the future of health care. Valerie brings
us in-depth knowledge and understanding of the specific health care
needs of a wide range of communities, and how to better prepare the
next generation of health care leaders to address those needs.
Andrew has deep experience in health technology research and access
strategies, as well as extensive skills in improving care delivery
through developing partnerships and sharing information. His broad
international experience in health care will help us grow to serve
more people in more nations around the world. We are pleased and
gratified to welcome them to the board.”
Montgomery Rice is the President and Dean of the Morehouse
School of Medicine, a medical school in Atlanta, Georgia, and has
served in that capacity since 2014 and as the EVP and Dean from
2011 to 2014. Prior to joining Morehouse School of Medicine, she
served as Dean of the School of Medicine and Senior Vice President
of Health Affairs at Meharry Medical College, and as the director
of the Center for Women’s Health Research, one of the nation’s
first research centers devoted to studying diseases that
disproportionately impact women of color. Montgomery Rice also
serves as a Council Member of the National Institute of Health
(NIH) National Center for Advancing Translational Science.
Montgomery Rice is a Member of the National Academy of Medicine and
a renowned infertility specialist and women’s health researcher.
She holds a bachelor’s degree in chemistry from the Georgia
Institute of Technology and a medical degree from Harvard School of
Medicine. Montgomery Rice completed her residency in obstetrics and
gynecology at Emory University School of Medicine and her
fellowship in reproductive endocrinology and infertility at Hutzel
Hospital in Detroit, MI.
Witty was CEO and a board member of GlaxoSmithKline plc (GSK), a
global pharmaceutical company, from 2008 to April, 2017. He joined
GSK in 1985 and, prior to 2008, served in various senior roles in
Europe, South Africa, the U.S. and Asia. He is Chancellor of the
University of Nottingham, a British public research university,
serving in that capacity since January 2013. He is a Business
Ambassador for the U.K. Prime Minister. Witty serves on the
Singapore Economic Development Board International Advisory
Committee, the Council at the London School of Hygiene and Tropical
Medicine and as an Advisor to the Bill and Melinda Gates
Foundation. Witty was knighted in the 2012 New Year Honours for
services to the economy and the U.K. pharmaceutical industry. He
also serves on the board of G1 Therapeutics, Inc.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health and
well-being company dedicated to helping people live healthier lives
and helping make the health system work better for everyone.
UnitedHealth Group offers a broad spectrum of products and services
through two distinct platforms: UnitedHealthcare, which provides
health care coverage and benefits services; and Optum, which
provides information and technology-enabled health services. For
more information, visit UnitedHealth Group at
www.unitedhealthgroup.com or follow @UnitedHealthGrp on
Twitter.
Click here to subscribe to Mobile Alerts for UnitedHealth
Group.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170807005244/en/
UnitedHealth GroupTyler Mason, 424-333-6122Vice President
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Apr 2024 to May 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From May 2023 to May 2024